Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1985 1
1988 1
1989 1
1995 1
1996 2
1997 2
1999 2
2000 3
2001 3
2002 3
2003 1
2005 1
2006 2
2007 1
2008 4
2009 3
2010 4
2011 6
2012 9
2013 10
2014 5
2015 7
2016 4
2017 9
2018 8
2019 10
2020 10
2021 6
2022 6
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit.
Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C. Leiter U, et al. Among authors: greinert r. J Dtsch Dermatol Ges. 2020 Apr;18(4):400-413. doi: 10.1111/ddg.14072_g. J Dtsch Dermatol Ges. 2020. PMID: 32291932 German.
S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren.
Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C. Heppt MV, et al. Among authors: greinert r. J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294. doi: 10.1111/ddg.14048_g. J Dtsch Dermatol Ges. 2020. PMID: 32130769 German.
Progress in Biophysics and Molecular Biology. Editorial.
McKinlay A, Vecchia P, Ziegelberger G, Greinert R. McKinlay A, et al. Among authors: greinert r. Prog Biophys Mol Biol. 2011 Dec;107(3):311. doi: 10.1016/j.pbiomolbio.2011.09.021. Epub 2011 Oct 12. Prog Biophys Mol Biol. 2011. PMID: 22019992 No abstract available.
Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
Ripoll C, Platzer S, Franken P, Aschenbach R, Wienke A, Schuhmacher U, Teichgräber U, Stallmach A, Steighardt J, Zipprich A; Liver-HERO Study Group. Ripoll C, et al. Trials. 2023 Apr 5;24(1):258. doi: 10.1186/s13063-023-07261-9. Trials. 2023. PMID: 37020315 Free PMC article. Clinical Trial.
Skin cancer prevention.
Greinert R. Greinert R. Eur J Cancer Prev. 2001 Apr;10(2):123-4. doi: 10.1097/00008469-200104000-00001. Eur J Cancer Prev. 2001. PMID: 11330451 No abstract available.
UV and children's skin.
Volkmer B, Greinert R. Volkmer B, et al. Among authors: greinert r. Prog Biophys Mol Biol. 2011 Dec;107(3):386-8. doi: 10.1016/j.pbiomolbio.2011.08.011. Epub 2011 Sep 3. Prog Biophys Mol Biol. 2011. PMID: 21907231 Review.
[The UV Protection Alliance in Germany-Purpose and goals].
Baldermann C; UV-Schutz-Bündnis. Baldermann C, et al. Ophthalmologe. 2022 Mar;119(3):223-233. doi: 10.1007/s00347-021-01543-w. Epub 2022 Jan 17. Ophthalmologe. 2022. PMID: 35039912 Free PMC article. Review. German.
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
Heppt MV, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, Bechara FG, Becker JC, Breitbart EW, Breuninger H, Diepgen T, Dirschka T, Eigentler T, El Gammal AKS, Felcht M, Flaig MJ, Follmann M, Fritz K, Grabbe S, Greinert R, Gutzmer R, Hauschild A, Hillen U, Ihrler S, John SM, Kofler L, Koelbl O, Krause-Bergmann A, Kraywinkel K, Krohn S, Langer T, Loquai C, Löser CR, Mohr P, Nashan D, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Voelter-Mahlknecht S, Vordermark D, Weichenthal M, Welzel J, Wermker K, Wiegand S, Garbe C, Berking C. Heppt MV, et al. Among authors: greinert r. J Dtsch Dermatol Ges. 2023 Oct;21(10):1249-1262. doi: 10.1111/ddg.15231. J Dtsch Dermatol Ges. 2023. PMID: 37845077
128 results